Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-08-28
1999-03-16
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514315, 514913, A61K 31445
Patent
active
058831088
ABSTRACT:
Methods for treating persons with glaucoma or ocular hypertension with polyamine antagonists and an IOP-lowering compounds are also disclosed.
REFERENCES:
patent: 4540408 (1985-09-01), Lloyd
patent: 4599353 (1986-07-01), Bito
patent: 4690931 (1987-09-01), Wick, et al.
patent: 4730013 (1988-03-01), Bondi et al.
patent: 4797413 (1989-01-01), Baldwin et al.
patent: 4861760 (1989-08-01), Mazuel et al.
patent: 4876250 (1989-10-01), Clark
patent: 4911920 (1990-03-01), Jani et al.
patent: 5093329 (1992-03-01), Woodward
patent: 5153192 (1992-10-01), Dean et al.
patent: 5212162 (1993-05-01), Missel et al.
patent: 5240923 (1993-08-01), Dean et al.
patent: 5321128 (1994-06-01), Stjernschantz et al.
patent: 5371078 (1994-12-01), Clark et al.
patent: 5378703 (1995-01-01), Dean et al.
patent: 5403841 (1995-04-01), Lang et al.
Tung, et al., "A quantitative analysis of the effects of excitatory neurotoxins on retinal ganglion cells in the chick," Visual Neurosci., 4:217-223 (1990).
Sisk, et al., "Histological changes in the inner retina of albino rats following intravitreal injection of monosodium L-glutamate,"Graefe's Arch. Clin. Exp. Ophthalmol., 223:250-258 (1985).
Siliprandi, et al., "N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina,"Visual Neurosci., 8:567-573 (1992).
Reif-Lehrer, et al., "Effects of monosodium glutamate on chick embryo retina in culture," Invest. Rohthalmol. Vis. Sci., 14(2):114-124 (1975).
Blanks, J.C., "Effects of monosodium glutamate on the isolated retina of the chick embryo as a function of age: A morphological study," Exp. Eye Res., 32:105-124 (1981).
Olney, et al., "The role of specific ions in glutamate neurotoxicity," Neurosci. Lett., 65:65-71 (1986).
Olney, et al., "The anti-excitotoxic effects of certian anesthetics, analgesics and sedative-hypnotics," Neurosci. LEtter., 68:29-34 (1986).
Price, et al., "CNQX potently and selectively blocks kainate excitotoxicity in the chick embryo retina," Soc. Neurosci. Abst., 14:418 (1988).
David, et al., "Involvement of excitatory neurotransmitters in the damage produced in chick embryo retinas by anoxia and extracellular high potassium," Exp. Eye Res., 46:657-662 (1988).
Caprioli, et al., "Large retinal ganglion cells are more susceptible to excitotoxic and hypoxic injury than small cells," Invest. Ophthalmol. Vis. Sci., 34(Suppl.): 1429 (1993).
Cummins, et al., "Electrophysiology of cultured retinal ganglion cells to investigate basic mechanics of damage," Glaucoma Update IV, 59-65 (1991).
Sucher, et al., "N-methyl-D-aspartate antagonists prevent kainate neurotoxicity in rat retinal ganglion cells in vitro," J. Neurosci., 11(4):966-971 (1991).
Massey, S., "Cell types using glutamate as a neurotransmitter in the vertebrate retina," N.N. Osborne and G.J. Chader (Eds.) Progress in Retinal Research, Ch. 9, Pergammon Press:Oxford, 399-425 (1990).
Miller, et al., "Excitatory amino acid receptors in the vertebrate retina," Retinal Transmitters and Modulators: Models for the Brain, (W.W. Morgan, Ed.) CRC Press, Inc., Boca Raton, II: 123-160 (1985).
Zeevalk, et al., "Action of the anti-ischemic agent ifenprodil on N-methyl-D-aspartate and kainate-mediated excitotoxicity," Brain Res., 522:135-139 (1990).
Ornstein, et al., "Antagonists of the NMDA receptor complx," DN& P, 7(1):5-12 (1994).
Lipton, S.A., "Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide," TINS, 16(12):527-532 (1993).
Quest Med., 33(2-3):75-85 (1980).
Knepper, et al., "Glycosaminoglycans and Outflow Pathways of the Eye and Brain," Pediat. Neurosci., 12:240-251 (1985-86).
Ingber, et al., "A Possible Mechanism for Inhibition of Angiogenesis by Angiostatic Steroids: Induction of Capillary Basement Membrane Dissolution," Endocrinology, 119(4):1768-75 (1986).
Clark, et al., "Angiostatic Steroids as a New Class of IOP Lowering Compounds," IOVS 35 (4):1057 (1994).
Rohen, Johannes W., "Why is Intraocular Pressure Elevated in Chronic Simple Glaucoma?" Ophthalmology, 90(7):758-765 (1983).
Johnson, et al., "Glaucoma: An Overview," Mayo Clin. Proc., 61:59-67 (1986).
Beal, M.F., "Mechanisms of excitotoxicity in neurologic diseases," FASEB J., 6:3338-3344 (1992).
Choi, D.W., "Excitotoxic cell death," J. Neurobiol., 23:1261-1276 (1992).
Sattayasai, et al., "Morphology of quisqualate-induced neurotoxicity in the chicken retina," Invest. Ophthalmol. Vis. Sci., 28:106-117 (1987).
Patent Abstracts of Japan, 13:208 (C-596), 16 May 1989 and JP 01 026518 A (Eisai Co Ltd), 27 Jan. 1989.
Patent Abstracts of Japan, 15:337 (C-0862), 27 Aug. 1991 and JP 03 128332 A (Eisai Co Ltd), 31 May, 1991.
Physicians' Desk Reference for Ophamology, 16 Edition, 1988. p. 11.
Alcon Laboratories Inc.
Fay Zohreh
Yeager Sally
LandOfFree
Combination therapy for treating glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination therapy for treating glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy for treating glaucoma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-818005